Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06431269
Other study ID # 21_0291
Secondary ID ID-RCB
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date June 2026

Study information

Verified date May 2024
Source University Hospital, Montpellier
Contact Marie VINCENTI, MD
Phone 04 67 33 66 39
Email m-vincenti@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease


Description:

Congenital heart disease (CHD) is the leading cause of birth defects. Over 90% of children born with CHD reach adulthood. 50% of them will develop a neurodevelopmental disorder (NDD) that could affect life and long-term prognosis, including scholar and social integration and health related quality of life. In France, there is a lack of medical resources to screen NDD in this population and to refer patients for appropriate and early treatment. Investigators plan to propose a systematic early screening of NDD by an Advanced Practice Nurse (APN) during the usual cardiac follow-up. Children with CHD aged 1 to 5 will be included. If NDD is suspected, the patient will be referred to a neuropsychologist for NDD diagnosis confirmation and management planning. Patients with higher NDD risks (neonatal cardiac surgery) will benefit from a systematic neuropsychologist evaluation. This study will investigate the feasibility and performance of an APN screening in this NDD-high risk population.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 270
Est. completion date June 2026
Est. primary completion date June 2026
Accepts healthy volunteers No
Gender All
Age group 1 Year to 5 Years
Eligibility Inclusion Criteria: - Congenital heart disease with stable status defined by last operation >3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion - Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life, - Patient aged 1 to 5 years. - No previous medical diagnosis of NDD - Parental or legal guardian's consent. - Social security affiliation (for France only) Exclusion Criteria: - Genetic or poly-malformative syndrome with usual neurodevelopmental care (CAMPS-type care network) - Neurodevelopmental status evaluation within the last 6 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Screening for neurodevelopmental disorders by an advanced practice nurse
Screening for neurodevelopmental disorders by an advanced practice nurse with Ages & Stages Questionnaires (ASQ-3) and Haute Autorité de Santé (HAS) identification scale

Locations

Country Name City State
France University Hospitial of Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensibility of the IPA screening for neurodevelopmental disorder (NDD) on the whole population studied This will be evaluated by comparing the results of the IPA screening (using both HAS scale and ASQ-3 parent's questionnaire) with results of the advanced neuropsychologist assessment. A positive IPA screening is defined by a NDD alert using the HAS scale and/or the ASQ-3 parent's questionnaire. The advanced neuropsychologist assessment will be done only for patients with CHD with a positive IPA screening. 4 months (to obtain the neurophysiologist assessment)
Secondary Feasibility of the IPA screening for NDD This rate will be calculated by dividing the complete IPA screenings (including HAS and the ASQ-3 parent's questionnaire) and children coming to the Complex Congenital Heart Defects consultation during the study period. 18 months
Secondary Performance (sensibility) of the IPA screening for NDD on the NDD high risk population This will be evaluated by comparing the results of the IPA screening (using both HAS scale and ASQ-3 parent's questionnaire) with results of the advanced neuropsychologist assessment. A positive IPA screening is defined by a NDD alert using the HAS scale and/or the ASQ-3 parent's questionnaire. The advanced neuropsychologist assessment will be done only for patients with CHD with a positive IPA screening. 4 months (to obtain the neurophysiologist assessment)
Secondary Performance (specificity) of the IPA screening for NDD on the NDD high risk population This will be evaluated by comparing the results of the IPA screening (using both HAS scale and ASQ-3 parent's questionnaire) with results of the advanced neuropsychologist assessment. A positive IPA screening is defined by a NDD alert using the HAS scale and/or the ASQ-3 parent's questionnaire. The advanced neuropsychologist assessment will be done only for patients with CHD with a positive IPA screening. 4 months (to obtain the neurophysiologist assessment)
Secondary Performance (positive predictive value) of the IPA screening for NDD on the NDD high risk population This will be evaluated by comparing the results of the IPA screening (using both HAS scale and ASQ-3 parent's questionnaire) with results of the advanced neuropsychologist assessment. A positive IPA screening is defined by a NDD alert using the HAS scale and/or the ASQ-3 parent's questionnaire. The advanced neuropsychologist assessment will be done only for patients with CHD with a positive IPA screening. 4 months (to obtain the neurophysiologist assessment)
Secondary Performance (negative predictive value) of the IPA screening for NDD on the NDD high risk population This will be evaluated by comparing the results of the IPA screening (using both HAS scale and ASQ-3 parent's questionnaire) with results of the advanced neuropsychologist assessment. A positive IPA screening is defined by a NDD alert using the HAS scale and/or the ASQ-3 parent's questionnaire. The advanced neuropsychologist assessment will be done only for patients with CHD with a positive IPA screening. 4 months (to obtain the neurophysiologist assessment)
Secondary Prevalence of NDD in the high risk population 18 months
See also
  Status Clinical Trial Phase
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Active, not recruiting NCT04935593 - Strengthening Social, Emotional and Behavioral Resilience N/A
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT04313283 - Translating Peer-to-Peer Support Into a Clinical Setting N/A
Completed NCT04562935 - Long-term Consequences of Admission for Pediatric Intensive Care Before One Year of Age
Not yet recruiting NCT05815095 - Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services
Recruiting NCT05017363 - Evaluation of the Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach) N/A
Completed NCT06251830 - Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
Completed NCT06052878 - Neurodevelopmental Outcome After Prenatal Anesthesia
Recruiting NCT06012903 - Lower Urinary Tract Symptoms and School Functioning in Children
Not yet recruiting NCT05490173 - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Not yet recruiting NCT05564871 - Effectiveness of Occupational Therapy Teleintervention in Pediatric N/A
Enrolling by invitation NCT02871674 - Good Night Project: Behavioural Sleep Interventions for Children With ADHD: A Randomised Controlled Trial N/A
Completed NCT01922791 - Nutrition and Pregnancy Intervention Study N/A
Active, not recruiting NCT05428657 - EC Brain Program for Children With Special Education Needs N/A
Recruiting NCT06111898 - Neuro-biomechanical Determinants for Motor Behavior in High-risk Infants
Recruiting NCT05658965 - KIDSHEART AND BRAIN : Early EEG Surgery Congenital Heart Disease Predict Onset of Neurodevelopmental Disorders
Recruiting NCT06057441 - Auditory and Visual Noise as Possible Non-pharmacological Treatment of ADHD in School Children N/A
Recruiting NCT06086951 - Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT N/A